Lumentum's Order Book Stretches to 2030, but Indium Phosphide Supply Is the Real Test
Published on 10/27/2026 at 17:41 | Editorial boerse-global.de
Lumentum's customers are already reserving capacity for 2030, according to media reports published today. Yet even with the company's expansion plans running at full tilt, roughly 70% of market demand could still go unmet in 2027. For investors, that mismatch shifts the focus from order intake to execution: the constraint on growth may not be a lack of buyers but a shortage of manufacturing capacity.
The demand itself is not in doubt. Management has said that capacity for AI optoelectronics products is effectively booked through early 2029 — a statement made to Bloomberg on 9 October. High-speed indium phosphide lasers are especially tight, and building new laser capacity takes about three years. That long lead time turns the bottleneck into more than a short-term delivery headache. It caps how quickly Lumentum can respond to additional orders, which means a full order book alone cannot guarantee a matching surge in revenue. Reservations are neither confirmed shipments nor booked sales; what matters is how fast the company can convert them into deliverable products.
A Possible Shield Against Chinese Rivals
Evercore ISI analyst Amit Daryanani points to another force behind the recent run in optical stocks: the prospect of import restrictions from the US Federal Communications Commission. Such measures could arrive by the end of the first quarter of 2027 and would effectively shut Chinese suppliers out of the US market for the next transceiver generation. No such rule has been decided. An expert in an Evercore discussion group put Chinese manufacturers' share of current transceiver supply at around two-thirds. Daryanani sees US suppliers and companies from allied countries as the likely beneficiaries of any restriction.
His view extends beyond trade policy. Optical connections, he argues, are a critical bottleneck in AI infrastructure, and he attributes the sector's recovery in part to renewed confidence in the durability of AI spending. That supports demand expectations but does nothing to resolve supply problems.
Should investors sell immediately? Or is it worth buying Lumentum?
Two Sides of the Materials Squeeze
Daryanani also flags stalled expansion plans in indium phosphide production, while reports from Asia indicate that manufacturing yields remain below the level needed to deliver the expected increase in supply. For Lumentum, this scarcity cuts both ways. Management has acknowledged that component availability has already limited shipments, and the company has reportedly reserved future substrate capacity at AXT.
StoneX initiated coverage yesterday with a buy rating and a price target of 1,200 US dollars, citing Lumentum's position in scarce lasers, cloud transceivers and optical switches. The scarcity is thus both part of the bullish case and an operational risk: it underscores how important Lumentum's products are to AI infrastructure, yet the same manufacturing limits can keep the company from fully serving demand.
Growth Is Already Visible
The expansion is not merely a forecast. In the fourth quarter of fiscal 2026, Lumentum posted revenue of 1.01 billion US dollars — a 109.3% increase over the prior-year quarter. For the first quarter of fiscal 2027, management projects revenue of between 1.225 and 1.275 billion US dollars, with adjusted earnings per share guided to a range of 4.05 to 4.35 US dollars. Results are due on 5 November after the market close. The stock rose 8.8% today.
Lumentum at a turning point? This analysis reveals what investors need to know now.
That upcoming report gives investors a chance to test the guidance against actual results — and, just as important, to hear whether capacity expansion is making headway and which products remain most constrained. Alongside manufacturing, the company lists customer concentration, competition and supply chains among its risks, and high margins will have to hold up as the business grows. Long-term capacity bookings do not erase those uncertainties.
Lumentum's growth story therefore hinges less on whether interest in its components exists than on how much of that demand it can actually serve. Progress in production and shipments would be firmer evidence than any further round of reservations.
Ad
Lumentum Stock: New Analysis - 27 October
Fresh Lumentum information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
